[144] Snowflake Inc. SEC Filing
Rhea-AI Filing Summary
Snowflake Inc. insider sale notice: This Form 144 reports a proposed sale of 176,922 common shares through Fidelity Brokerage Services with an aggregate market value of $39,388,776.19, to be sold on 09/25/2025 on the NYSE. The shares are reported as acquired by exercise of an option granted on 08/27/2019, with payment in cash. The filer previously sold 318,533 shares on 09/23/2025 for $72,581,088.65 and 85,099 shares on 09/24/2025 for $19,172,557.91. The filing lists total common shares outstanding of 338,800,000. The notice includes the statutory representation that the seller is not aware of undisclosed material adverse information.
Positive
- Full transaction details provided: class, broker, share counts, prices and dates are disclosed
- Source of shares identified: option granted 08/27/2019, with cash payment on exercise
Negative
- No 10b5-1 plan date provided: filing does not state whether sales are under a prearranged trading plan
- Signature/date not clearly shown: the notice section does not include an explicit signature date in the provided text
Insights
TL;DR: Insider option exercise and scheduled resale of ~177k SNOW shares, following two prior day dispositions; size is small relative to outstanding shares.
This Form 144 shows an insider selling 176,922 shares valued at about $39.4M on 09/25/2025, following two recent sales totaling 403,632 shares and gross proceeds of roughly $91.8M. Relative to the reported 338.8M shares outstanding, the individual transactions represent a de minimis ownership transfer (<0.2%). There is no earnings or operational data in the filing, and the source of the shares is an option granted in 2019 with cash payment on exercise. For investors, this is a routine disclosure of insider liquidity rather than a material corporate event.
TL;DR: The filing documents routine insider monetization via option exercise and open-market sales; disclosure appears to follow regulatory requirements.
The notice identifies the transaction type (option exercise) and provides broker and sale-date details required under Rule 144. The signer affirms no undisclosed material adverse information. There is no indication of a 10b5-1 plan adoption date or other trading-plan detail in the text provided. From a governance perspective, the filing is a standard compliance disclosure and does not itself signal governance change or material risk to shareholders.